CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Acelrx Pharmaceuticals Inc  (ACRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

ACRX's Revenue Year on Year Growth by Quarter and Year

Acelrx Pharmaceuticals Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ACRX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 6.44 1.73 0.23
III Quarter September - 3.37 15.43 4.83
II Quarter June 2.66 4.53 1.92 0.07
I Quarter March 3.11 3.03 0.18 0.10
FY   5.77 17.37 19.26 5.23

Financial Statements
Acelrx Pharmaceuticals Inc's second quarter 2017 Revenue $ 2.66 millions ACRX's Income Statement
Acelrx Pharmaceuticals Inc's second quarter 2016 Revenue $ 4.53 millions Quarterly ACRX's Income Statement
ACRX's Growth by Division See ACRX's Growth by Segment

ACRX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 272.25 % 652.17 % -99.17 %
III Quarter September - -78.16 % 219.46 % 778.18 %
II Quarter June -41.3 % 135.94 % 2642.86 % -82.93 %
I Quarter March 2.64 % 1583.33 % 80 % -89.36 %
FY   - -9.81 % 268.26 % -



ACRX Revenue Growth Comment
Acelrx Pharmaceuticals Inc reported fall in Revenue in the second quarter by -41.3% to $ 2.66 millions, from the same quarter in 2016.
The drop in the second quarter Acelrx Pharmaceuticals Inc's Revenue compares unfavorably to the Company's average Revenue doubling of 444.57%.

Looking into second quarter results within Major Pharmaceutical Preparations industry 103 other companies have achieved higher Revenue growth. While Acelrx Pharmaceuticals Inc' s Revenue drop of -41.3% ranks overall at the positon no. 3138 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #104
Healthcare Sector #378
Overall #3138
Revenue Y/Y Growth Statistics
High Average Low
2609.86 % 444.57 % -99.18 %
(Jun 30 2015)   (Dec 31 2014)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ACRX's Competitors
Revenue Growth for Acelrx Pharmaceuticals Inc's Suppliers
Revenue Growth for ACRX's Customers

You may also want to know
ACRX's Annual Growth Rates ACRX's Profitability Ratios ACRX's Asset Turnover Ratio ACRX's Dividend Growth
ACRX's Roe ACRX's Valuation Ratios ACRX's Financial Strength Ratios ACRX's Dividend Payout Ratio
ACRX's Roa ACRX's Inventory Turnover Ratio ACRX's Growth Rates ACRX's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions
Brookdale Senior Living Inc. -5.75 %$ -5.748 millions
Cord Blood America, Inc. -5.91 %$ -5.907 millions
Genesis Healthcare, Inc. -6.06 %$ -6.055 millions